Polyphenols and Chronic Myeloid Leukemia: Emerging Therapeutic Opportunities
Background/Objectives: Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by the BCR–ABL fusion gene, whose constitutive tyrosine kinase activity drives leukemogenesis. Although tyrosine kinase inhibitors (TKIs) have revolutionized treatment, drug resistance and leukemic s...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI AG
2025-08-01
|
| Sarja: | Hemato |
| Aiheet: | |
| Linkit: | https://www.mdpi.com/2673-6357/6/3/28 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|